Skip to main content
. 2016 Apr 7;64(5):1774–1784. doi: 10.1002/hep.28526

Table 1.

Summary of Models Discussed

Type of model/injury Species Intervention In vivo or in vitro Effect of intervention on liver Reference
Viral hepatitis Mouse Platelet depletion In vivo Hepatoprotective 47
Viral hepatitis Mouse Inhibition of platelet activation In vitro and in vivo Hepatoprotective 12, 13, 48, 49, 50, 51
Viral hepatitis Mouse Blocking platelet binding to endothelium In vitro and in vivo Variable can be either hepatoprotective or hepatotoxic 5, 12
Isolated HSEC coculture with platelets Human Blocking platelet binding to endothelium In vitro Hepatoprotective (reduced effector cell recruitment) 5
Ischemia‐reperfusion Mouse Blocking platelet‐Kupffer cell interaction In vivo Hepatoprotective (reduction in steatosis) 42, 45, 46
Thermal injury Mouse Blocking platelet binding In vivo Hepatotoxic (reduced neutrophil‐mediated repair) 30
Acute cholestasis Mouse Inhibition of platelet activation In vivo Hepatoprotective 58, 59, 60
Chronic cholestasis Mouse Platelet depletion/inhibition of platelet activation In vivo Hepatotoxic (worsens fibrosis) 62, 63